Medications

New ALS drug approved in Canada while still under FDA review

An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness.

Medical research

COVID vaccine development was quick. What's holding HIV back?

While multiple effective COVID-19 vaccines were developed with astonishing speed, it has been more than 40 years since University of Rochester alumnus Michael Gottlieb, M.D., first described the disease that became known ...

Psychology & Psychiatry

Demographics, not bias, best predict traffic stops

When it comes to predicting how often Black drivers will be stopped by traffic police versus how often white drivers will be stopped, you're better off looking at census numbers than asking people how they feel about other ...

Diseases, Conditions, Syndromes

Omicron : What we know and what we don't

Omicron is a variant of COVID-19 first sequenced in South Africa with cases now present in over 20 countries and on all continents.

page 1 from 3